Terms ending in 2036
Every in-force patent on CureVac AG's record whose computed term ends in 2036, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 11,149,278 | Artificial Nucleic Acid Molecules for Improved Protein Expression In force · High confidence | Curevac SE | In force | High confidence | |
| US 11,254,951 | Artificial Nucleic Acid Molecules In force · High confidence | Curevac SE | In force | High confidence | |
| US 10,780,054 | Lyophilization of RNA In force · High confidence | Curevac Manufacturing GmbH | In force | High confidence | |
| US 10,293,058 | RNA Containing Composition for Treatment of Tumor Diseases In force · High confidence | Curevac SE | In force | High confidence | |
| US 10,869,935 | RNA Containing Composition for Treatment of Tumor Diseases In force · High confidence | Curevac SE | In force | High confidence | |
| US 10,918,740 | RNA Containing Composition for Treatment of Tumor Diseases In force · High confidence | Curevac SE | In force | High confidence | |
| US 11,559,570 | PRIME-BOOST REGIMENS INVOLVING ADMINISTRATION OF AT LEAST ONE mRNA CONSTRUCT In force · High confidence | Curevac SE | In force | High confidence | |
| US 10,517,827 | Dry Powder Composition Comprising Long-Chain RNA In force · High confidence | Curevac SE | In force | High confidence | |
| US 10,729,654 | Dry Powder Composition Comprising Long-Chain RNA In force · High confidence | Curevac SE | In force | High confidence | |
| US 11,179,337 | Dry Powder Composition Comprising Long-Chain RNA In force · High confidence | Curevac SE | In force | High confidence | |
| 12 more term ends in 2036 · Pro | |||||
10 of 22 patents shown. Soonest term end first, then patent number.
Pro members see all 22.
18 of these are in force and held by CureVac AG.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.